Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rich

Showing results (91-100 of 181) with videos related to

Pageof 19
Sort By:
Nature|September 27, 1990
Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cellsD P Rich, M P Anderson, R J Gregory, et al.
Neuron|May 1, 1992
Cystic fibrosis transmembrane conductance regulator: a chloride channel with novel regulationM J Welsh, M P Anderson, D P Rich, et al.
Journal of Viral Hepatitis|June 24, 2006
Comparison of two PEG-interferon alpha-2b doses (1.0 or 1.5 microg/kg) combined with ribavirin in interferon-naïve patients with chronic hepatitis C and up to moderate fibrosisB Meyer-Wyss, P Rich, Hp Egger, et al.
The Journal of Infection|December 3, 2014
Neurological, visual, and MRI brain scan findings in 87 South African patients with HIV-associated cryptococcal meningoencephalitisA Loyse, A Moodley, P Rich, et al.
The British Journal of Dermatology|February 9, 2019
Efficacy and safety of mirikizumab (LY3074828) in the treatment of moderate-to-severe plaque psoriasis: results from a randomized phase II studyK Reich, P Rich, C Maari, et al.
Cancer Research|May 4, 2019
The Small GTPase ARF6 Activates PI3K in Melanoma to Induce a Prometastatic StateJae Hyuk Yoo, Samuel W Brady, Lehi Acosta-Alvarez, et al.
Journal of the American Academy of Dermatology|June 19, 1998
Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenailR K Scher, D Breneman, P Rich, et al.
Journal of the American Academy of Dermatology|June 19, 1998
Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenailP Rich, R K Scher, D Breneman, et al.
Nature Communications|August 4, 2024
Tumour-intrinsic endomembrane trafficking by ARF6 shapes an immunosuppressive microenvironment that drives melanomagenesis and response to checkpoint blockade therapyYinshen Wee, Junhua Wang, Emily C Wilson, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
ARF6-dependent endocytic trafficking of the Interferon-γ receptor drives adaptive immune resistance in cancerYinshen Wee, Junhua Wang, Emily C Wilson, et al.
Pageof 19

Showing results (91-100 of 181) with videos related to

Sort By:
Pageof 19
Nature|September 27, 1990
Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cellsD P Rich, M P Anderson, R J Gregory, et al.
Neuron|May 1, 1992
Cystic fibrosis transmembrane conductance regulator: a chloride channel with novel regulationM J Welsh, M P Anderson, D P Rich, et al.
Journal of Viral Hepatitis|June 24, 2006
Comparison of two PEG-interferon alpha-2b doses (1.0 or 1.5 microg/kg) combined with ribavirin in interferon-naïve patients with chronic hepatitis C and up to moderate fibrosisB Meyer-Wyss, P Rich, Hp Egger, et al.
The Journal of Infection|December 3, 2014
Neurological, visual, and MRI brain scan findings in 87 South African patients with HIV-associated cryptococcal meningoencephalitisA Loyse, A Moodley, P Rich, et al.
The British Journal of Dermatology|February 9, 2019
Efficacy and safety of mirikizumab (LY3074828) in the treatment of moderate-to-severe plaque psoriasis: results from a randomized phase II studyK Reich, P Rich, C Maari, et al.
Cancer Research|May 4, 2019
The Small GTPase ARF6 Activates PI3K in Melanoma to Induce a Prometastatic StateJae Hyuk Yoo, Samuel W Brady, Lehi Acosta-Alvarez, et al.
Journal of the American Academy of Dermatology|June 19, 1998
Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenailR K Scher, D Breneman, P Rich, et al.
Journal of the American Academy of Dermatology|June 19, 1998
Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenailP Rich, R K Scher, D Breneman, et al.
Nature Communications|August 4, 2024
Tumour-intrinsic endomembrane trafficking by ARF6 shapes an immunosuppressive microenvironment that drives melanomagenesis and response to checkpoint blockade therapyYinshen Wee, Junhua Wang, Emily C Wilson, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
ARF6-dependent endocytic trafficking of the Interferon-γ receptor drives adaptive immune resistance in cancerYinshen Wee, Junhua Wang, Emily C Wilson, et al.
Pageof 19